ES2052273T3 - Composicion que contiene un epitopo b de la glicoproteina que envuelve un retrovirus y un epitopo t de una proteina distinta de dicho retrovirus. - Google Patents

Composicion que contiene un epitopo b de la glicoproteina que envuelve un retrovirus y un epitopo t de una proteina distinta de dicho retrovirus.

Info

Publication number
ES2052273T3
ES2052273T3 ES90913220T ES90913220T ES2052273T3 ES 2052273 T3 ES2052273 T3 ES 2052273T3 ES 90913220 T ES90913220 T ES 90913220T ES 90913220 T ES90913220 T ES 90913220T ES 2052273 T3 ES2052273 T3 ES 2052273T3
Authority
ES
Spain
Prior art keywords
epitope
glycoprotein
enveloping
retroviruses
retrovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913220T
Other languages
English (en)
Inventor
Marc Girard
Jean-Claude Gluckman
El Mustapha Bahraoui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie
Institut Pasteur
Original Assignee
Universite Pierre et Marie Curie
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie, Institut Pasteur filed Critical Universite Pierre et Marie Curie
Application granted granted Critical
Publication of ES2052273T3 publication Critical patent/ES2052273T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION TRATA DE UN COMPUESTO QUE COMBINA, ESPECIALMENTE BAJO LA FORMA DE AL MENOS UNA MOLECULA HIBRIDA, O EN EL SENO DE LA MISMA, AL MENOS UN PEPTIDO INMUNOGENICO QUE CONTIENE UN EPITOPE B QUE PROVIENE DE LA GLICOPROTEINA ENV DE UN VIRUS DE INMUNODEFICIENCIA PATOGENA, DE UN VIRUS HTLVI O HTLVII, O DE LA PROTEINA CORRESPONDIENTE DE UN VIRUS DE INMUNODEFICIENCIA, HTLVI O HTLVII DIFERENTE. SE DESCRIBEN IGUALMENTE COMPUESTOS DE VACUNA QUE CONTIENEN ESTAS MOLECULAS HIBRIDAS. TAMBIEN TRATA DE LOS ADN Y ARN RECOMBINADOS QUE CODIFICAN ESTAS MOLECULAS, ASI COMO LOS EPITOPES T Y B.
ES90913220T 1989-08-18 1990-08-17 Composicion que contiene un epitopo b de la glicoproteina que envuelve un retrovirus y un epitopo t de una proteina distinta de dicho retrovirus. Expired - Lifetime ES2052273T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911044A FR2650954B1 (fr) 1989-08-18 1989-08-18 Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida

Publications (1)

Publication Number Publication Date
ES2052273T3 true ES2052273T3 (es) 1994-07-01

Family

ID=9384804

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913220T Expired - Lifetime ES2052273T3 (es) 1989-08-18 1990-08-17 Composicion que contiene un epitopo b de la glicoproteina que envuelve un retrovirus y un epitopo t de una proteina distinta de dicho retrovirus.

Country Status (8)

Country Link
EP (1) EP0439601B1 (es)
AT (1) ATE105190T1 (es)
CA (1) CA2039141A1 (es)
DE (1) DE69008701T2 (es)
DK (1) DK0439601T3 (es)
ES (1) ES2052273T3 (es)
FR (1) FR2650954B1 (es)
WO (1) WO1991002544A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类
US5519114A (en) * 1993-10-29 1996-05-21 University Of Florida Research Foundation, Inc. Retroviral superantigens, superantigen peptides, and methods of use
RU2146930C1 (ru) * 1998-04-10 2000-03-27 Ткаченко Виталий Васильевич Способ лечения вич-инфекции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002277A2 (en) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
WO1989006543A1 (en) * 1988-01-12 1989-07-27 Genelabs Incorporated Htlv-i peptide antigen and assay
JPH01301699A (ja) * 1988-02-10 1989-12-05 Immulogic Pharmaceut Corp 難治性の感染症の治療用ペプチド
JPH02150283A (ja) * 1988-07-21 1990-06-08 Takeda Chem Ind Ltd 発現プラスミドおよびその用途

Also Published As

Publication number Publication date
ATE105190T1 (de) 1994-05-15
CA2039141A1 (fr) 1991-02-19
EP0439601A1 (fr) 1991-08-07
FR2650954A1 (fr) 1991-02-22
EP0439601B1 (fr) 1994-05-04
DE69008701T2 (de) 1994-09-15
DE69008701D1 (de) 1994-06-09
WO1991002544A1 (fr) 1991-03-07
FR2650954B1 (fr) 1992-02-28
DK0439601T3 (da) 1994-06-13

Similar Documents

Publication Publication Date Title
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
ES2174931T3 (es) Anticuerpos monoclonales que se unen al precursor del antigeno de rechazo de tumores mage-1, mage-1 recombinante y peptidos inmunogenos derivados de mage-1.
MX9102028A (es) Antagonistas de piperidinilcanforsulfonil oxitocida.
NZ335612A (en) A composition containing cytotoxic specificT-cell epitopes being either Rev and/or Tat proteins from HIV virus for prevention and treatment of human immunodeficiency virus (HIV) infection
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
ATE274578T1 (de) Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis
EP1278534A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING THE REPRODUCTION OF HIV-1
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
ES2052273T3 (es) Composicion que contiene un epitopo b de la glicoproteina que envuelve un retrovirus y un epitopo t de una proteina distinta de dicho retrovirus.
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
DK0470980T3 (da) Syntetiske peptider til en HIV-1-vaccine
ES2031834T3 (es) Benzazepinas fusionadas.
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
ES2087311T3 (es) Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos.
DK0472706T3 (da) Induktion af beskyttelse mod viral infektion
ES2193014T3 (es) 3-metiloct-6-enoles 6-sustituidos.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
EP0717752A4 (en) THERAPEITIC INGREDIENTS
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
WO1994006921B1 (en) Recombinant retroviral vector against felv and/or fiv
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
ATE205220T1 (de) Hepatitis-a-impfstoff
ES2080193T3 (es) Anticuerpos monoclonales contra la gp120 de vih.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 439601

Country of ref document: ES